| For: | Li SF, Ouyang X, Feng S, Wan MZ, Zhou KN, Wen BY, Yin YZ, Yi H, Chen XY. Oncohepatology: Navigating liver injury in the era of modern cancer therapy. World J Hepatol 2025; 17(6): 106932 [PMID: 40606932 DOI: 10.4254/wjh.v17.i6.106932] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i6/106932.htm |
| Number | Citing Articles |
| 1 |
Ehab E. Sharata, Mina Ezzat Attya, Marwa M. Khalaf, Remon Roshdy Rofaeil, Ramadan A. M. Hemeida, Amira M. Abo-Youssef. Unraveling chemotherapy-evoked hepatic dysfunction: a deep dive into cyclophosphamide-related liver injury. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(2): 2097 doi: 10.1007/s00210-025-04583-0
|
| 2 |
Chao Zhang, Shan Li, Jiawei Ren, Xiaohui Wen. Optimizing ribociclib dosing in breast cancer with brain metastasis patients using a physiologically based pharmacokinetic model. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-15561-x
|
| 3 |
Qiyang Han, Xiaoying Zhang, Liting Chen, Yicheng Zhang. Chimeric antigen receptor T‑cell therapy in chronic viral infections: a review. Journal of Translational Medicine 2026; 24(1) doi: 10.1186/s12967-025-07582-0
|
| 4 |
Lisi Liu, Xun Duan, Baozhao Ju. Recent advances in non-alcoholic steatohepatitis-associated hepatocellular carcinoma: immune cells, metabolic dysregulation, and therapeutic strategies. Frontiers in Oncology 2026; 15 doi: 10.3389/fonc.2025.1744299
|
| 5 |
Kota Tsuruya, Tatehiro Kagawa. Metabolic Vulnerability and Tamoxifen Hepatotoxicity: The Importance of Multidisciplinary Collaboration. Hepatology Research 2025; doi: 10.1111/hepr.70105
|
